About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Corpus Callosal Oligodendroglioma: A rare entity
Charandeep Singh Gandhoke1, Simran K Syal2, Daljit Singh1, Ravindra Kumar Saran3
Departments of 1Neurosurgery and 3Pathology, Maulana Azad Medical College and G.B. Pant Institute of Post Graduate Medical Education and Research (GIPMER), New Delhi; 2Department of Pediatrics, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, India.
Corresponding Author:
Dr. Charandeep Singh Gandhoke 
Email: charandeepsingh2008@gmail.com
Received: 23-MAR-2017 Accepted: 24-MAY-2017 Published Online: 05-JUL-2017
DOI: http://dx.doi.org/10.17659/01.2017.0063
Abstract
Introduction: Oligodendroglioma’s (ODG) are primary glial brain tumors that are divided into classical and anaplastic ODG’s. Common pathologies encountered in the corpus callosum include primary central nervous system lymphomas and glioblastoma. Corpus callosal ODG is a rare entity. Case Report: A 54 year old male presented with headache since 6 months and weakness of right upper and lower limbs since 4 months. Radiological imaging was suggestive of a heterogeneous minimally enhancing mass arising from the corpus callosum and extending bilaterally into the frontal lobes (left more than right). Left frontal craniotomy and tumor decompression was done. Final histopathological report was “oligodendroglioma grade II but likely to behave in an aggressive manner”. Patient received adjuvant chemo-radiation and on his latest follow up two years post-surgery, radiological imaging showed only gliotic changes in the brain. Conclusion: Corpus callosal oligodendroglioma is a rare entity. The treatment for anaplastic and aggressive ODG’s should include gross total resection (wherever possible) or tumor decompression followed by adjuvant chemo-radiation.
Keywords : Brain Neoplasms, Corpus callosum, Frontal Lobe, Glioma, Oligodendroglioma.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports

abortion pill online

Secure abortion pill tablets. There he could simply order pill for abortion online generic.There we could simply order generic site.
Last updated on Apr 05, 2024